“Olympics on steroids” takes a high-tech, F1-style angle on athletics

It seems the Enhanced Games are on like Donkey Kong, with multi-million dollar investments from Peter Thiel and other high-profile VCs. Performance-enhancing drugs are welcome – indeed, this could become an early preview of a transhuman Olympics.Contin… Continue reading “Olympics on steroids” takes a high-tech, F1-style angle on athletics

New molecule triggers burst of white blood cells to fight infections

White blood cells are important foot soldiers in the immune system, but their numbers can be cut by health conditions or treatments like chemotherapy. Yale scientists have now discovered a molecule that can be given to quickly boost their numbers back … Continue reading New molecule triggers burst of white blood cells to fight infections

New drug triggers “calcium storm” to choke cancer cells to death

No matter how important something is, too much of anything is bad for you. Scientists have now put that principle to work to kill cancer, with a new drug that causes calcium to build up and choke the tumor to death.Continue ReadingCategory: Medical, Sc… Continue reading New drug triggers “calcium storm” to choke cancer cells to death

Drug beliefs produce a dose-dependent effect in the brain, study finds

Researchers have shown, for the first time, that a person’s beliefs about nicotine influences brain activity, producing a dose-dependent effect that was only thought to occur with pharmaceutical agents. In addition to providing an explanation for why i… Continue reading Drug beliefs produce a dose-dependent effect in the brain, study finds

New antibiotic family kills superbugs in a way they can’t resist

Antibiotic-resistant bacteria are poised to become a global health concern in the coming decades. In the race to develop new weapons, scientists from Texas A&M have created a novel family of antibacterial polymers that can kill ‘superbugs’ in a way the… Continue reading New antibiotic family kills superbugs in a way they can’t resist

Single-dose drug to quash anxiety passes another trial milestone

An effective single-dose, long-term treatment for anxiety could be within reach, with the phase 2b clinical trial of MM-120 reported to have passed the stage with flying colors. The makers, MindMed, now plan to hold an end-of-phase meeting with the US … Continue reading Single-dose drug to quash anxiety passes another trial milestone

Once-a-day pill for stubborn cancer delivers a 62.5% positive response

In what has already been tagged as a “game-changer” for cancer treatment, the potent once-a-day tablet known as divarasib has continued to impress at Phase 1b trial stage, outperforming not just current therapies but its previous trial results.Continue… Continue reading Once-a-day pill for stubborn cancer delivers a 62.5% positive response